Related Experiment Video
Updated: Jul 8, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Evaluation of drug interaction microcomputer software: Part 2--Drug Interactions Advisor
Hospital Pharmacy
|January 9, 1989
Summary
The Drug Interactions Advisor software offers good usability but poor clinical performance for evaluating drug interactions. It is valuable for initial screening but not for in-depth analysis.
Area of Science:
- Pharmacology and Clinical Pharmacy
- Health Informatics
Background:
- Drug interactions pose a significant risk to patient safety.
- Clinical decision support systems aim to mitigate these risks.
- The Drug Interactions Advisor is a software tool designed to assist healthcare professionals.
Purpose of the Study:
- To evaluate the Drug Interactions Advisor software using general and specific criteria.
- To assess its clinical performance and utility in identifying potential drug interactions.
Main Methods:
- Evaluation based on general usability criteria (installation, learning, use).
- Assessment of specific criteria including documentation, technical support, scope of coverage, clinical documentation, and update frequency.
- Analysis of the quality and quantity of interaction information provided.
Main Results:
- Installation, learning, and ease of use were rated as good.
- Documentation, technical support, scope of coverage, clinical documentation, and update frequency received fair ratings.
- Overall clinical performance was rated as poor due to the quality and quantity of interaction information.
Conclusions:
- The Drug Interactions Advisor has value as an initial screening tool for potential drug interactions.
- It is not a reliable source for comprehensive or evaluative drug interaction information.
- Further development is needed to improve its clinical utility for detailed analysis.
Related Concept Videos
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...